Albany International Corporation · NYSE:AIN
Albany International — Q4 2025 Earnings Presentation
18 slides from Albany International's earnings presentation, Feb 24, 2026
Slide 1: Q4 2025 Earnings Update
PROPRIETARY & CONFIDENTIAL Q4 2025 EARNINGS UPDATE February 24, 2026 This document contains proprietary, confidential, and/or trade secret information. Possessing, using, copying or disclosing this document to or for the benefit of any third party without prior written consent may result in criminal
Slide 2: Safe Harbor Statement
SAFE HARBOR STATEMENT This presentation contains certain items, such as earnings before interest, taxes, depreciation and amortization (EBITDA), Adjusted EBITDA, Adjusted EBITDA Margins, Free Cash Flow and net debt, as well certain income and expense items on a per share basis, that could be conside
Slide 3: Strategic Overview
STRATEGIC OVERVIEW Two unique end markets from one shared expertise in weaving technology MACHINE CLOTHING ENGINEERED COMPOSITES Global leader in paper machine fabrics and Long-term growth engine process belts Grew organically from weaving and composites manufacturing capabilities Leading position i
Slide 4: Q4 Consolidated Financials
Q4 CONSOLIDATED FINANCIALS (Millions USD, except per share data) Q4 2025 Q4 2024 Total Revenue* $321.2 $286.9 Adjusted** EBITDA $57.3 $50.0 Adjusted** EBITDA Margin 17.8% 17.4% Adjusted** Diluted Earnings Per Share $0.65 $0.58 ** For a full reconciliation of GAAP to non-GAAP results, please refer to
Slide 5: Machine Clothing End Markets
MACHINE CLOTHING END MARKETS Global stability with softness in Asia GEOGRAPHY PAPER GRADE AMERICAS TISSUE STABLE Bright spot globally with planned new investments supporting Growth in Tissue partly impacted by industry consolidation largely growing demand. impacting packaging and corrugator segments
Slide 6: Engineered Composites End Markets
ENGINEERED COMPOSITES END MARKETS Broad portfolio performing; portfolio reshaping to enhance profitability COMMERCIAL DEFENSE AEROSPACE AEROSPACE GROWING STABLE LEAP deliveries increasing with customer demand. F-35 program at rate. BETA certification underway and production ramping. Focusing new bus
Slide 7: Q4 Machine Clothing Financials
Q4 MACHINE CLOTHING FINANCIALS (Millions USD) Q4 2025 Q4 2024 Revenue $177.5 $188.0 Adjusted* EBITDA $48.6 $53.7 Adjusted* EBITDA Margin 27.4% 28.5% * For a full reconciliation of GAAP to non-GAAP results, please refer to the appendix as well as the tables and Basis of Presentation included in the e
Slide 8: Q4 Engineered Composites Financials
Q4 ENGINEERED COMPOSITES FINANCIALS (Millions USD) Q4 2025 Q4 2024 Revenue* $143.7 $98.8 Adjusted** EBITDA $18.5 $5.6 Adjusted** EBITDA Margin 12.9% 6.1% * For a full reconciliation of GAAP to non-GAAP results, please refer to the appendix as well as the tables and Basis of Presentation included in
Slide 9: Q4 Cash Flow and Balance Sheet
Q4 CASH FLOW AND BALANCE SHEET (Millions USD) Q4 2025 YTD Free Cash Flow $51.0 $81.0 R&D Spend $12.1 $48.0 Capex $22.7 $72.0 Share Repurchase $17 $186.0 * For a full reconciliation of GAAP to non-GAAP results, please refer to the appendix as well as the tables and Basis of Presentation included in t
Slide 10: Financial Snapshot
FINANCIAL SNAPSHOT Strong balance sheet and cash flow supports disciplined capital allocation Balanced capital allocation strategy For the full-year ended December 31, 2025 directed toward organic growth through CAPEX and consistent R&D investment, along with return of cash to $72M 10% CAPEX Spend O
Slide 11: Guidance
GUIDANCE Q1 2026 broadly consistent with recent trends Outlook for the First Quarter of 2026: Underlying trends persist into Q1 Machine Clothing • Consolidated revenue between $275 million and $285 million • Americas impacted by an equipment failure at a North American facility • Machine Clothing re
Slide 12: Question and Answer
PROPRIETARY & CONFIDENTIAL QUESTION AND ANSWER This document contains proprietary, confidential, and/or trade secret information. Possessing, using, copying or disclosing this document to or for the benefit of any third party without prior written consent may result in criminal and/or civil liabilit
Slide 13: Appendix
PROPRIETARY & CONFIDENTIAL APPENDIX This document contains proprietary, confidential, and/or trade secret information. Possessing, using, copying or disclosing this document to or for the benefit of any third party without prior written consent may result in criminal and/or civil liability. 13
Slide 14: Appendix
APPENDIX GAAP to non-GAAP reconciliation albint.com | AIN | ©2025 Albany International Corp | Distribution subject to restrictions on first page. 14
Slide 15: Appendix
APPENDIX GAAP to non-GAAP reconciliation albint.com | AIN | ©2025 Albany International Corp | Distribution subject to restrictions on first page. 15
Slide 16: Appendix
APPENDIX GAAP to non-GAAP reconciliation albint.com | AIN | ©2025 Albany International Corp | Distribution subject to restrictions on first page. 16
Slide 17: Appendix
APPENDIX GAAP to non-GAAP reconciliation Financial tables and reconciliations of non-GAAP measures to comparable GAAP measures- Year-to-date information revised to include the third-quarter CH-53 contracts reserve program adjustment, now determined to represent an operational item that should be inc
Slide 18: Appendix
APPENDIX GAAP to non-GAAP reconciliation albint.com | AIN | ©2025 Albany International Corp | Distribution subject to restrictions on first page. 18